Parenteral Drug (India) share news and announcements

BSE: 524689Pharmaceuticals & Biotechnology

Trading suspended since 3 Feb 2025

Last traded ₹2.90 on 21 Aug 2023

Parenteral Drug (India) share news and announcements

782 announcements, routine notices left out, newest first. Page 2 of 16.

Mar 2024
- 15 Mar · Committee Meeting Updates
  Outcome of Committee Meeting held on March 14, 2024. (opens in a new tab)
- 15 Mar · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
  We would like to inform that the sixth meeting of Committee of Creditors (CoC), pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR) .... (opens in a new tab)
- 13 Mar · Committee Meeting Updates
  Committee Meeting to be held on March 14, 2024. (opens in a new tab)
- 13 Mar · Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
  Prior Intimation of the 8th Meeting of Committee of Creditors ('CoC') of Parenteral Drugs (India) Ltd., the Corporate Debtor Scheduled on Thursday, 14th March, 2024 at 05:00 PM. (opens in a new tab)
Feb 2024
- 27 Feb
  Corporate Insolvency Resolution Process (opens in a new tab)
- 27 Feb · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
  Post-Facto Intimation of the Seventh Meeting of Committee of Creditors ('CoC') of Parenteral Drugs (India) Ltd., the Corporate Debtor was held on Friday, 16th February, 2024 at 02:30 PM. (opens in a new tab)
Jan 2024
- 23 Jan · Updates
  Post-Facto Intimation of the publication of Form G of Parenteral Drugs (India) Ltd., the Corporate Debtor which was published on Sunday, 21st January, 2024. (opens in a new tab)
- 23 Jan · Corporate Insolvency Resolution Process (CIRP)-Public Announcement
  Post-Facto Intimation of the publication of Form G of Parenteral Drugs (India) Ltd., the Corporate Debtor which was published on Sunday, 21st January, 2024 (opens in a new tab)
- 20 Jan · Committee Meeting Updates
  Outcome of Committee Meeting held on January 19, 2024. (opens in a new tab)
- 20 Jan · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
  Post-Facto Intimation of the Sixth Meeting of Committee of Creditors ('CoC') of Parenteral Drugs (India) Ltd., the Corporate Debtor was held on Friday, 19th January, 2024 at 12:00 Noon (opens in a new tab)
- 17 Jan · Committee Meeting Updates
  Outcome of Committee Meeting held on January 15, 2024. (opens in a new tab)
- 16 Jan · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
  We would like to inform that the fifth meeting of Committee of Creditors (CoC), pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR) .... (opens in a new tab)
Dec 2023
- 15 Dec · Updates
  Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) and in accordance with the requirements of sub- clause 16(c) of Clause A of Part A of Schedule III of Listing Regulations, I would like to inform you that the Hon'ble NCLT, Mumbai Division Bench Court I vide the order dated 17.10.2023 (a certified copy of order was received on 27.10.2023) passed an order of replacement of Interim Resolution Professional Mr. Kairav Trivedi to Mr. Prawincharan Prafulcharan Dwary as the Resolution Professional (bearing Registration No: IBBI/IPA-002/IP-N00331/2017-2018/10937) in the captioned matter (opens in a new tab)
Mar 2023
- 13 Mar · Corporate Insolvency Resolution Process
  Corporate Insolvency Resolution ProcessSubject: 1st COC meetingThis is to inform you that the 1st Meeting of Committee of Creditors of Parenteral Drugs (India) Limited Under CIRP will be held on 13/03/2023 at 4:30 PM through video conference / other audio-visual method. (opens in a new tab)
- 13 Mar · Corporate Insolvency Resolution Process
  Corporate Insolvency Resolution ProcessSubject: Formation of COCThis is to inform you that, the Committee of Creditors of Parenteral Drugs (India) Limitedunder CIRP has been formed as on 03/03/2023, and same has been informed to Hon ble NCLT. (opens in a new tab)
- 13 Mar · Corporate Insolvency Resolution Process
  Corporate Insolvency Resolution ProcessSubject: List of CreditorsThis is to inform you that, the list of Creditors of Parenteral Drugs (India) Limited Under CIRP has been prepared on 03/03/2023 and uploaded in IBBI Website on 04/03/2023 and the same has been informed to Hon ble NCLT. (opens in a new tab)
- 11 Mar · Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
  This is to inform you that the 1st Meeting of Committee of Creditors of Parenteral Drugs (India) Limited Under CIRP will be held on 13/03/2023 at 4:30 PM through video conference / other .... (opens in a new tab)
- 11 Mar · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
  This is to inform you that, the Committee of Creditors of Parenteral Drugs (India) Limited under CIRP has been formed as on 03/03/2023, and same has been informed to Hon'ble NCLT. (opens in a new tab)
- 11 Mar · Corporate Insolvency Resolution Process (CIRP)-List of Creditors
  This is to inform you that, the list of Creditors of Parenteral Drugs (India) Limited Under CIRP has been prepared on 03/03/2023 and uploaded in IBBI Website on 04/03/2023 and the same .... (opens in a new tab)
Feb 2023
- 23 Feb · Corporate Insolvency Resolution Process (CIRP)-Public Announcement
  Notice is hereby given that the National Company Law Tribunal, Mumbai has ordered the commencement of Corporate Insolvency Resolution Process of Parenteral Drugs (India) Limited vide order, .... (opens in a new tab)
- 23 Feb · Management
  I hereby intimate that Parenteral Drugs (India) Limited (The CD) that CIRP has been initiated in respect of the CD under the provisions of Insolvency and Bankruptcy Code, 2016 ('Code') .... (opens in a new tab)
- 20 Feb · Corporate Insolvency Resolution Process
  Public Announcement as per Corporate Insolvency Resolution Process (opens in a new tab)
- 20 Feb · Corporate Insolvency Resolution Process
  Initiation of Corporate Insolvency Resolution Process against the Company (opens in a new tab)
Aug 2022
- 24 Aug · Communication to shareholders as per Reg 30
  Communication to shareholders as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding update on the operations of the Company. (opens in a new tab)
- 24 Aug · Announcement Under Regulation 30 (LODR)- Updates
  Parenteral Drugs (India) Limited hereby submits intimation under Regulation 30 of SEBI( Listing Obligation and Disclosure Requirements), 2015 regarding update on the operations of the Company. (opens in a new tab)
- 10 Aug · Management
  Resignation of Pooja Choukse as Company Secretary of the company w.e.f. 31-Jul-2022. (opens in a new tab)
- 10 Aug · Management
  Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding Resignation of Ms. Pooja Choukse Company Secretary and Compliance Officer .... (opens in a new tab)
- 9 Aug · Communication to shareholders as per Reg 30
  Communication to shareholders as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 about the resignation of Ms. Pooja Choukse as a Company Secretary and Compliance Officer of the Company with effect from 31.07.2022. (opens in a new tab)
- 9 Aug · Management
  Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding Resignation of Ms. Pooja Choukse as a Company Secretary and Compliance .... (opens in a new tab)
Jun 2022
- 20 Jun · Legal
  Exchange had sought clarification from Parenteral Drugs (India) Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is enclosed. (opens in a new tab)
- 15 Jun · Legal
  Exchange has sought clarification from Parenteral Drugs (India) Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is awaited.
- 14 Jun · Related Party Transaction
  Related party transaction for the period ended March 2022 (opens in a new tab)
- 14 Jun · Disclosures Of Related Party Transactions On Consolidated Basis For Half Year Ended On 31-03-2022.
  Parenteral Drugs (India) Limited hereby submits disclosures of Related Party Transactions on Consolidated basis pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure .... (opens in a new tab)
May 2022
- 31 May · Results
  Financial results for the period ended March 31, 2022. (opens in a new tab)
- 30 May · Results
  Financial results for the period ended March 31, 2022. (opens in a new tab)
- 30 May · Results
  Parenteral Drugs (India) Limited hereby submits Annual Audited Financial Results for the Quarter and Financial Year ended on 31st March, 2022. (opens in a new tab)
- 30 May · Board meeting
  Board Meeting held on 30-May-2022 to consider financial statements for the period ended March 2022 and Other business matters (opens in a new tab)
- 30 May · Board meeting
  Parenteral Drugs (India) Limited hereby intimates about the Outcome of the Board Meeting for the following items: 1. Considered, approved and taken on record the Annual Audited Financial .... (opens in a new tab)
- 18 May · Board meeting
  Board Meeting to be held on 30-May-2022 to consider financial statements for the period ended on 31st March 2022 and Other business matters. (opens in a new tab)
- 18 May · Board meeting
  PARENTERAL DRUGS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve 1. The Annual Audited .... (opens in a new tab)
- 13 May · General updates
  Confirmation Certificate under Regulation 74(5) of SEBI (Depositories and Participant) Regulation, 2018 (opens in a new tab)
- 13 May · Statement Of Investor Complaints For The Quarter Ended March 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 13 May · Compliance - Compliance Certificate Under Regulation 40(10) Of SEBI (LODR) Regulations, 2015
  Parenteral Drugs (India) Limited hereby submits Compliance Certificate under Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 13 May · Compliances - Compliance Certificate For The Period Ended 31St March, 2022
  Parenteral Drugs (India) Limited hereby submits Compliance Certificate pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 (opens in a new tab)
Apr 2022
- 5 Apr · Disclosure
  Promoter/Promoter Group of Parenteral Drugs (India) Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022 (opens in a new tab)
Mar 2022
- 28 Mar · One Time Settlement
  One Time Settlement. (opens in a new tab)
- 28 Mar · Announcement Under Regulation 30 SEBI (LODR) - Updates (OTS)
  In continuation of earlier intimation regarding One Time Settlement proposal given by the Company and accepted by the Consortium of Banks, it is informed the Stock Exchange that the Company .... (opens in a new tab)
- 1 Mar · Management
  Parenteral Drugs (india) Limited hereby intimate the stock Exchange regarding the Regularization of the appointment of Mrs. Chhaya Gupta (DIN: 09486091) as an Independent Director of the Company. (opens in a new tab)
- 1 Mar · Meeting
  Parenteral Drugs(India) Limited hereby submits Scrutinizer Report of Extra Ordinary General Meeting held on 1st March 2022. (opens in a new tab)
- 1 Mar · Results
  Parenteral Drugs (India) Limited hereby submits Disclosure of remote E- Voting and voting at Extra-Ordinary General meeting held on 1st March, 2022 along with Scrutinizer Report (opens in a new tab)